Donepezil and memantine Approval Status
- FDA approved: No
- Generic name: donepezil and memantine
- Company: Forest Laboratories, Inc. and Adamas Pharmaceuticals Inc.
- Treatment for: Alzheimer's Disease
Memantine ER/Donepezil is a fixed-dose combination (FDC) in development for the treatment of moderate to severe dementia of the Alzheimer’s type.
FDA Approval Status for donepezil and memantine
|Mar 4, 2014||Forest Submits NDA for Memantine ER and Donepezil Fixed-Dose Combination for Alzheimer’s Disease|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.